hematopoietic cell transplantation

  1. P

    Trial Report REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial, 2026, Huang et al

    This post is about a press release in 2024. The study is now published in 2026. See post #7 A large company specialising in umbilical cord blood has conducted a successful phase 2a trial in Long Covid patients (20 LC patients, 10 controls). The UCB contains Haemopoietic Progenitor Cells (which...
  2. O

    Orthostatic intolerance syndromes after hematopoietic cell transplantation, 2021, Vecchié et al

    Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience Abstract Background Hematopoietic cell transplantation (HCT) is an established and potentially curative therapeutic option for...
Back
Top